AngioDynamics CFO exits the company

By staff writers

October 23, 2019 -- Interventional technology developer AngioDynamics said that executive vice president and chief financial officer (CFO) Michael Greiner will be leaving the company.

Stephen Trowbridge, senior vice president and general counsel, will assume the role of interim CFO while the firm begins its search for a permanent successor. AngioDynamics emphasized that Greiner's departure is unrelated to its business performance, financial reporting, or controls.

Greiner will also remain with the firm up to the filing of its second fiscal quarter 10-Q form to facilitate a smooth transition of duties, the vendor said.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking